3Coil E,Botey A,Alvarez L,et a1.Serum Cysmtin C asanew marker for noninvasive estimation of glomerularfiltration rate and as a marker for early renal impair-ment[J].Am JKidney Dis,2000,36(1):29-34.
4Ozmen B,Ozmen D,Turgan N,et a1.Association betweenhomocysteine and renal function in patients with type 2dia-belesmellitus[J].Annals of Clinical&Laboratory Science,2002,32(3):279-86.
5陆再英;钟南山.内科学[M]{H}北京:人民卫生出版社,200891-92.
6Miyoshi H,Mizuguchi Y,Oishi Y. Early detection of abnormal left atrial-left ventricular-arterial coupling in preclinical patients with cardiovascular risk factors:evaluation by two-dim ensionalspeckle-trackingechocardiography[J].{H}Eur J Echocardiography,2011,(06):431-439.
7Praddaude F,Cousins SW,Pecher C. Angiotensin Ⅱ-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium[J].{H}EXPERIMENTAL EYE RESEARCH,2009,(01):109-118.
8Punzi H,Neutel JM,Kereiakes DJ. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension:the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) Study[J].Ther Adv Cardiovasc Dis,2010,(04):209-221.
10Dhingra R,Pencina MJ,Schrader P. Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community[J].{H}CIRCULATION,2009,(08):1101-1107.
